Health ❯Obesity ❯Treatment Options

Medications

GLP-1 Drugs Wegovy Semaglutide Self-Pay Pharmacy

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

Doctors Question Safety and Efficacy of GLP-1 Supplements and Drugs for Weight Loss